Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034903
Filing Date
2024-11-13
Accepted
2024-11-13 16:08:07
Documents
81
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q omer20240930_10q.htm   iXBRL 10-Q 1271965
2 EXHIBIT 10.1 ex_735126.htm EX-10.1 40367
3 EXHIBIT 31.1 ex_711207.htm EX-31.1 12800
4 EXHIBIT 31.2 ex_711208.htm EX-31.2 13458
5 EXHIBIT 32.1 ex_711209.htm EX-32.1 6511
6 EXHIBIT 32.2 ex_711210.htm EX-32.2 6532
12 ex_735126img001.jpg GRAPHIC 53483
13 ex_735126img002.jpg GRAPHIC 50090
  Complete submission text file 0001437749-24-034903.txt   7450745

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA omer-20240930.xsd EX-101.SCH 75815
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20240930_def.xml EX-101.DEF 477177
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20240930_lab.xml EX-101.LAB 396646
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20240930_pre.xml EX-101.PRE 502432
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omer-20240930_cal.xml EX-101.CAL 52662
84 EXTRACTED XBRL INSTANCE DOCUMENT omer20240930_10q_htm.xml XML 1215545
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 241454182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)